SKI Market

Indian Indices

Nifty

25,149.85 -205.40
(-0.81%)

Sensex

82,500.47 -689.81
( -0.83%)

Bank Nifty

56,754.70 -201.30
( -0.35%)

Nifty IT

37,693.25 -683.40
( -1.78%)

Global Indices

Nasdaq

44,384.39 -287.26
(-0.64%)

Dow Jones

6,279.98 -21.48
(-0.34%)

Hang Seng

39,553.98 -92.38
(-0.23%)

Nikkei 225

8,941.12 -34.54
(-0.38%)

Forex

USD-INR

85.73 0.00
(0.00%)

EUR-INR

100.42 -0.13
(-0.13%)

GBP-INR

116.48 -0.10
(-0.08%)

JPY-INR

0.58 0.00
(-0.13%)

YOU ARE HERE :
HOME
Markets
Equity
Profit and Loss

EQUITY - MARKET SCREENER

Remus Pharmaceuticals Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

78788

INE0O5T01011

205.5515954

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

REMUS

55.1

1096.74

EPS(TTM)

Face Value()

Div & Yield %

16.89

Particulars(INCOME)	Mar 2024 ( Cr)	Mar 2023 ( Cr)	Mar 2022 ( Cr)	Mar 2021 ( Cr)	Mar 2020 ( Cr)	Mar 2019 ( Cr)
Sales Turnover	29.67	9.23	20.26	14.58	7.13	9.36
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	29.67	9.23	20.26	14.58	7.13	9.36
Other Income	0.15	0.21	1.54	0.54	0.00	0.00
Stock Adjustments	0.00	-0.02	0.00	0.00	0.00	0.19
Total Income	29.82	9.42	21.80	15.12	7.13	9.55
EXPENDITURE :
Raw Materials	27.74	8.65	20.16	14.50	7.18	9.36
Power & Fuel Cost	0.00	0.01	0.00	0.00	0.00	0.00
Employee Cost	0.15	0.13	0.09	0.01	0.02	0.01
Other Manufacturing Expenses	0.02	0.04	0.08	0.00	0.00	0.00
Selling & Administrative Expenses	0.53	0.52	0.42	0.22	0.02	0.03
Miscellaneous Expenses	0.17	0.12	0.01	0.00	0.00	0.00
Less : Pre-operative Expenses Capitalised	0.00	0.00	0.00	0.00	0.00	0.00
Total Expenditure	28.61	9.46	20.77	14.74	7.22	9.40
Operating Profit	1.21	-0.05	1.03	0.37	-0.10	0.13
Interest	0.18	0.00	0.00	0.00	0.00	0.00
Gross Profit	1.03	-0.05	1.03	0.37	-0.10	0.13
Depreciation	0.02	0.02	0.00	0.00	0.00	0.00
Profit Before Tax	1.01	-0.07	1.03	0.37	-0.10	0.13
Tax	0.33	0.01	0.27	0.07	0.00	0.03
Fringe Benefit tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	-0.03	0.00
Reported Net Profit	0.69	-0.08	0.77	0.30	-0.07	0.10
Extraordinary Items	-0.11	0.00	0.00	0.00	0.00	0.00
Adjusted Net Profit	0.80	-0.08	0.77	0.30	-0.07	0.10
Adjustment below Net Profit	-0.77	0.00	-0.23	0.00	0.00	0.00
P & L Balance brought forward	0.78	0.85	0.30	0.00	0.09	0.00
Statutory Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
Appropriations	0.00	0.00	0.00	0.00	0.00	0.00
P & L Balance carried down	0.69	0.78	0.84	0.30	0.02	0.09
Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00	0.00
Equity Dividend %	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Per Share(Rs)	0.00	0.00	0.00	0.00	0.00	0.00
Earnings Per Share-Unit Curr	1.61	-0.51	7.40	60.79	-14.50	19.52
Earnings Per Share(Adj)-Unit Curr	1.60	-0.18	7.40	60.79	-14.50	19.52
Book Value-Unit Curr	11.63	28.05	18.10	70.64	14.34	28.84
Book Value(Adj)-Unit Curr	11.52	9.93	18.10	70.64	14.34	28.84

25,149.85 -205.40 (-0.81%)

82,500.47 -689.81 ( -0.83%)

56,754.70 -201.30 ( -0.35%)

37,693.25 -683.40 ( -1.78%)

44,384.39 -287.26 (-0.64%)

6,279.98 -21.48 (-0.34%)

39,553.98 -92.38 (-0.23%)

8,941.12 -34.54 (-0.38%)

85.73 0.00 (0.00%)

100.42 -0.13 (-0.13%)

116.48 -0.10 (-0.08%)

0.58 0.00 (-0.13%)